Genmab — November 2025

[E_L]

Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior Unsecured Notes and Completion of Syndication of New Senior Secured Term Loan Facility https://ir.genmab.com/news-releases/news-release-details/genmab-announces-pricing-private-offering-senior-secured-notes - 6.250% senior secured notes due 2032 and 7.250% senior unsecured notes due 2033

[E_L]

Nov 19, 2025 1:00 PM CET
Jefferies Healthcare Conference https://ir.genmab.com/events-presentations

[bikube]

I hope someone listen and refere the headpoints, I can´t follow Jan´s speedtalks.

[lahn1]

Bikuben - download appen Quartr. Der har du alle events optaget og med transcripts og mulighed for at søge i transcripts

[bikube]

Tak lahn de transcripts forstår jeg bedre.

[peter12]

Som jeg hørte det, ville de komme med to nye bi-specifikke og en ny ADC med Profound linker I år ?!
De regnede nu med peaksale på Rina-S på 2mia$ og at peto ville sælge for 1mia$ i 2029

[Sukkeralf]

Ja tre nye IND’er i år er ret flot - og endda BsAb-ADC.

[bikube]

JnJ vin FDA traditional nod for Dara Faspro in AL amyloidosis. siger Seeking Alfa.

[bikube]

Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

[bikube]

Amgen får fuld FDA godkendelse for Imdelltra i SCLC. også iflg. S.A.

[E_L]

Epkinly gets a second-line follicular nod And AbbVie and Genmab scoop their ASH presentation with new data.
https://www.oncologypipeline.com/apexonco/epkinly-gets-second-line-follicular-nod

[Sukkeralf]

Kesimpta peak salg forventes over 6 milliarder dollars:

[Sukkeralf]

Novartis venter vækst på 5-6 pct. på mellemlang sigt

Novartis forventer samtidig, at salget af sklerosemidlet Kesimpta, som Genmab har del i, fortsat når et topsalg på mere end 6 mia. dollar.

(medwatch.dk)

[Solsen]

Virkelig flot

[E_L]

Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street. https://www.investors.com/news/technology/biotech-stocks-antibody-drug-conjugates-adcs-cancer-treatment-chemotherapy/

[Helge_LarsenPI-redaktør]

Transcript : Genmabs præsentation på Jefferies Healthcare Conference med Q&A https://proinvestor.com/investornyt/1385876/transcript-genmabs-praeligsentation-paring-jefferies-healthcare-conference-med-qampa

[E_L]

ASH Late breaker for Teclistamab + Daratumumab
https://x.com/JacobPlieth/status/1992984045823942775/photo/1

[E_L]

@Plimsoller looks like only 6 again, i imagine you were probably hoping for something on epco, but this is nice i would say

[E_L]

seems that dump into that large auction follows huge auction in Novo?

[E_L]

ASH25 LBA-6
Abstract Title : Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice
of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients
(Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
https://meetings-api.hematology.org/api/abstract/vmpreview/304640 Spectacular
...